Institutional Ownership
Myriad Genetics Inc
CUSIP 62855J104COMMYGNQ1 2026
13D / 13G Filings
58
Schedule 13D/13G on record
Beneficial Filers
18
Distinct reporting persons
Largest Stake
18.4%
Max % of class reported
Institutional Holders
193
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
58 filings · latest Feb 11, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 11, 2026 | Integrated Core Strategies (Us) LLC | 13G/A | 11.0% | 6.70M | SEC |
| 2 | Feb 9, 2026 | State Street Corporation | 13G | 6.4% | 5.97M | SEC |
| 3 | Jan 13, 2026 | Glenview Capital Management, LLC | 13G | 5.3% | 4.94M | SEC |
| 4 | Nov 12, 2025 | Integrated Core Strategies (Us) LLC | 13G/A | 11.0% | 4.75M | SEC |
| 5 | Nov 12, 2025 | Barclays PLC | 13G/A | 4.2% | 3.94M | SEC |
| 6 | Oct 31, 2025 | The Vanguard Group | 13G/A | 8.5% | 7.88M | SEC |
| 7 | Aug 14, 2025 | Disciplined Growth Investors Inc /Mn | 13G/A | 0.8% | 754.0K | SEC |
| 8 | Aug 12, 2025 | Wellington Management Group LLP | 13G/A | — | 9 | SEC |
| 9 | Aug 12, 2025 | Barclays PLC | 13G | 5.3% | 4.90M | SEC |
| 10 | Aug 4, 2025 | Integrated Core Strategies (Us) LLC | 13G/A | 11.0% | 4.92M | SEC |
48 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Myriad Genetics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 8.89M | $40.00M |
| 2 | Millennium Management LLC | 6.67M | $30.01M |
| 3 | Glenview Capital Management, LLC | 5.41M | $24.35M |
| 4 | D. E. Shaw & Co., Inc. | 4.50M | $20.25M |
| 5 | State Street Corp | 4.42M | $19.91M |
| 6 | Morgan Stanley | 3.17M | $14.26M |
| 7 | Goldman Sachs Group Inc | 2.37M | $10.65M |
| 8 | Geode Capital Management, LLC | 2.32M | $10.44M |
| 9 | Jacobs Levy Equity Management, Inc | 2.09M | $9.40M |
| 10 | Federated Hermes, Inc. | 1.98M | $8.89M |